india

DRDO’s anti-Covid drug priced at Rs 990 per sachet

The drug was approved by the Drugs Controller General of India (DGCI) earlier this month for emergency use as an adjunct therapy in moderate to severe coronavirus patients.

The anti-Covid drug developed by the Defence Research and Development Organisation (DRDO) has been priced at Rs 990 per sachet, news agency ANI reported citing officials.

The drug, developed in collaboration with Hyderabad-based pharma company Dr Reddy’s Laboratories (DRL), will be provided to central and state government hospitals at a discounted price, officials said.

Earlier, Union Defence Minister Rajnath Singh had said that 10,000 sachets of the anti-Covid drug, known by the name 2-deoxy-D-glucose (2-DG), will be available in the market initially.

“This 2-DG drug developed by DRDO and DRL is a perfect example of India’s scientific prowess and a milestone in the efforts towards self-reliance,” Singh had said.

The drug was approved by the Drugs Controller General of India (DGCI) earlier this month for emergency use as an adjunct therapy in moderate to severe coronavirus patients.

During its release, the government said that clinical trial data show that the molecule helps in faster recovery of patients hospitalised with Covid-19, and reduces their dependence on supplemental oxygen.

The drug accumulates in virus-infected cells, and prevents the growth of the virus by stopping viral synthesis and energy production. Its selective accumulation in virally-infected cells makes this drug unique, a government release said.

“The drug will be of immense benefit to the people suffering from Covid-19,” it added.

The drug is available in powder form in a sachet, and can be taken orally after dissolving in water.

Source: Read Full Article